| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/27/2026 | ±3.1% | +5.8% | under-priced |
| 04/24/2026 | ±3.3% | +6.9% | under-priced |
| 02/05/2026 | ±2.9% | -3.1% | under-priced |
| 10/24/2025 | ±3.0% | -3.3% | under-priced |
| 07/23/2025 | ±2.0% | +11.6% | under-priced |
| 04/23/2025 | ±3.3% | -6.4% | under-priced |
| 02/04/2025 | ±3.5% | +1.2% | over-priced |
| 10/23/2024 | ±1.9% | +2.8% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | — | $6.7B | $681M |
| Q1 FY2026 | — | $6.6B | $930M |
| Q4 FY2025 | — | $7.4B | $876M |
| Q3 FY2025 | — | $7.0B | $609M |
BKR (BKR) reports in 90 days, with the next report estimated for 01/25/2027. Across the last 8 reports, options priced an average ±2.9% earnings move while the stock actually moved 5.1% on average — the market has tended to under-price BKR's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue down 2.4%. QuantLogix's live 5-factor engine currently reads BKR as a buy at 61/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →